BlueCrest Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-5,338
| Closed | -$520K | – | 1427 |
|
|
2018
Q4 | $520K | Buy |
5,338
+3,681
| +222% | +$359K | 0.03% | 335 |
|
|
2018
Q3 | $230K | Buy |
+1,657
| New | +$230K | 0.01% | 1178 |
|
|
2018
Q1 | – | Sell |
-229,097
| Closed | -$27.4M | – | 1669 |
|
|
2017
Q4 | $27.4M | Buy |
+229,097
| New | +$27.4M | 0.75% | 10 |
|
|
2016
Q1 | – | Sell |
-3,053
| Closed | -$582K | – | 1136 |
|
|
2015
Q4 | $582K | Buy |
+3,053
| New | +$582K | 0.02% | 507 |
|
|
2015
Q3 | – | Sell |
-13,251
| Closed | -$2.4M | – | 993 |
|
|
2015
Q2 | $2.4M | Buy |
+13,251
| New | +$2.4M | 0.07% | 251 |
|